Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tarsus Pharmaceuticals (TARS) Debt Ratio (2022 - 2025)

Tarsus Pharmaceuticals has reported Debt Ratio over the past 4 years, most recently at 0.13 for Q4 2025.

  • Quarterly results put Debt Ratio at 0.13 for Q4 2025, down 32.39% from a year ago — trailing twelve months through Dec 2025 was 0.13 (down 32.39% YoY), and the annual figure for FY2025 was 0.13, down 32.39%.
  • Debt Ratio for Q4 2025 was 0.13 at Tarsus Pharmaceuticals, down from 0.14 in the prior quarter.
  • Over the last five years, Debt Ratio for TARS hit a ceiling of 0.19 in Q4 2024 and a floor of 0.08 in Q2 2022.
  • Median Debt Ratio over the past 4 years was 0.12 (2025), compared with a mean of 0.13.
  • Biggest five-year swings in Debt Ratio: skyrocketed 72.12% in 2024 and later tumbled 32.39% in 2025.
  • Tarsus Pharmaceuticals' Debt Ratio stood at 0.09 in 2022, then soared by 31.69% to 0.11 in 2023, then skyrocketed by 69.68% to 0.19 in 2024, then tumbled by 32.39% to 0.13 in 2025.
  • The last three reported values for Debt Ratio were 0.13 (Q4 2025), 0.14 (Q3 2025), and 0.15 (Q2 2025) per Business Quant data.